A Bill to Promote Safe and Ethical Clinical Trials of Drugs and Other Test Articles on People Overseas
Washington, DC: U.S. G.P.O., 2006. 11 p. [Online]. Available: http://frwebgate.access.gpo.gov/cgi-bin/useftp.cgi?IPaddress=220.127.116.11&filename=h5641ih.pdf&directory=/diskb/wais/data/109_cong_bills [17 July 2006]
Showing items related by title, author, creator and subject.
A Bill to Amend the Toxic Substances Control Act to Protect the Environment and Human Health from Adverse Effects Caused by the Release of Genetically Engineered Micro-Organisms into the Environment, to Promote the Safe Use of Genetically Engineered Micro-Organisms, and for Other Purposes. 99th Congress, 1st Session, S. 1967 United States. Congress. Senate (1985)
A Bill to Amend the Federal Food, Drug, and Cosmetic Act to Provide That Drugs Will Be Regulated Under the Act Solely to Assure Their Safety, to Promote the Efficient and Fair Treatment of New Drug Applications, and for Other Purposes. H.R. 11446, 95th Congress, 2d Session Unknown creator (United States. Congress. House, 1978-03-09)
The promise and pitfalls of clinical trials overseas. Big pharma has big incentives, including cost savings and more powerful studies, to launch trials in developing countries. But can companies avoid the ethical potholes? Bagla, Pallava; Normile, Dennis; Xi, Chen (2008-10-10)